These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25246505)

  • 21. Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overload.
    Pepe A; Positano V; Santarelli MF; Sorrentino F; Cracolici E; De Marchi D; Maggio A; Midiri M; Landini L; Lombardi M
    J Magn Reson Imaging; 2006 May; 23(5):662-8. PubMed ID: 16568436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal iron deposition by magnetic resonance imaging in pediatric β-thalassemia major patients: Relation to renal biomarkers, total body iron and chelation therapy.
    ElAlfy MS; Khalil Elsherif NH; Ebeid FSE; Ismail EAR; Ahmed KA; Darwish YW; Ibrahim AS; Elghamry IRF; Shokrey NA; Alajeil DN
    Eur J Radiol; 2018 Jun; 103():65-70. PubMed ID: 29803388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multislice multiecho T2* cardiac magnetic resonance for the detection of heterogeneous myocardial iron distribution in thalassaemia patients.
    Positano V; Pepe A; Santarelli MF; Ramazzotti A; Meloni A; De Marchi D; Favilli B; Cracolici E; Midiri M; Spasiano A; Lombardi M; Landini L
    NMR Biomed; 2009 Aug; 22(7):707-15. PubMed ID: 19322807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 5-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients.
    Cassinerio E; Roghi A; Orofino N; Pedrotti P; Zanaboni L; Poggiali E; Giuditta M; Consonni D; Cappellini MD
    Ann Hematol; 2015 Jun; 94(6):939-45. PubMed ID: 25563596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How does iron deposition modify the myocardium? A feature-tracking cardiac magnetic resonance study.
    Asadian S; Rezaeian N; Hosseini L; Toloueitabar Y; Komasi MMH; Shayan L
    Int J Cardiovasc Imaging; 2021 Nov; 37(11):3269-3277. PubMed ID: 34105082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart rate variability in β-thalassaemia major with or without cardiac siderosis.
    Alp A; Ozdogan O; Guloglu CC; Turker M; Atabay B
    Cardiol Young; 2014 Apr; 24(2):263-7. PubMed ID: 23402458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate-term evaluation of a pratical chelation protocol based on stratification of thalassemic patients by serum ferritin and magnetic resonance imaging cardiac t2*.
    Ha SY; Mok AS; Chu WC; Rasalkar DD; Cheuk DK; Chiang AK; Ho MH; Chan GC
    Hemoglobin; 2011; 35(3):199-205. PubMed ID: 21599432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of echocardiography parameters with cardiac magnetic resonance imaging in transfusion-dependent thalassaemia major.
    Aessopos A; Giakoumis A; Fragodimitri C; Karabatsos F; Hatziliami A; Yousef J; Gotsis E; Berdoukas V; Karagiorga M
    Eur J Haematol; 2007 Jan; 78(1):58-65. PubMed ID: 17038018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of iron overload in very young children with limited thalassemia care resources in South China.
    Au WY; Li CF; Fang JP; Chen GF; Sun X; Li CG; Zhang XH; Wu XD; Gao HY; Hao WG; Rasalkar D; Deng M; Mok SP; Tricta F; Chu WC
    Hemoglobin; 2014; 38(2):119-26. PubMed ID: 24502375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac iron overload in sickle-cell disease.
    Meloni A; Puliyel M; Pepe A; Berdoukas V; Coates TD; Wood JC
    Am J Hematol; 2014 Jul; 89(7):678-83. PubMed ID: 24664847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial tissue characterization by segmental T2 mapping in thalassaemia major: detecting inflammation beyond iron.
    Meloni A; Pistoia L; Positano V; Martini N; Borrello RL; Sbragi S; Spasiano A; Casini T; Bitti PP; Putti MC; Cuccia L; Allò M; Massei F; Sanna PMG; De Caterina R; Quaia E; Cademartiri F; Pepe A
    Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1222-1230. PubMed ID: 37070652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with beta-thalassaemia major: comparison between different chelation regimens.
    Christoforidis A; Haritandi A; Tsatra I; Tsitourides I; Karyda S; Athanassiou-Metaxa M
    Eur J Haematol; 2007 Jan; 78(1):52-7. PubMed ID: 17042760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial.
    Fernandes JL; Sampaio EF; Fertrin K; Coelho OR; Loggetto S; Piga A; Verissimo M; Saad ST
    Am J Med; 2013 Sep; 126(9):834-7. PubMed ID: 23830536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between myocardial T2 values and cardiac volumetric and functional parameters in β-thalassemia patients evaluated by cardiac magnetic resonance in association with serum ferritin levels.
    Liguori C; Pitocco F; Di Giampietro I; de Vivo AE; Schena E; Cianciulli P; Zobel BB
    Eur J Radiol; 2013 Sep; 82(9):e441-7. PubMed ID: 23639773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major.
    Westwood MA; Wonke B; Maceira AM; Prescott E; Walker JM; Porter JB; Pennell DJ
    J Magn Reson Imaging; 2005 Aug; 22(2):229-33. PubMed ID: 16028255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with beta thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events.
    Patton N; Brown G; Leung M; Bavishi K; Taylor J; Lloyd J; Lee SH; Tay L; Worthley S
    Intern Med J; 2010 Jun; 40(6):419-26. PubMed ID: 19460052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias.
    Fragasso A; Ciancio A; Mannarella C; Gaudiano C; Scarciolla O; Ottonello C; Francone M; Nardella M; Peluso A; Melpignano A; Veglio MR; Quarta G; Turchetti C
    Eur J Intern Med; 2011 Feb; 22(1):62-5. PubMed ID: 21238896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study.
    Pepe A; Meloni A; Rossi G; Caruso V; Cuccia L; Spasiano A; Gerardi C; Zuccarelli A; D'Ascola DG; Grimaldi S; Santodirocco M; Campisi S; Lai ME; Piraino B; Chiodi E; Ascioti C; Gulino L; Positano V; Lombardi M; Gamberini MR
    Br J Haematol; 2013 Nov; 163(4):520-7. PubMed ID: 24111905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.